Task: Answer the multiple-choice question.
Query: Which compound exhibits a -34.033% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CC(C)N(Cc1nc(-c2ccccc2)no1)C(=O)COc1ccccc1
b.) COc1ccc(C2NC(=O)NC(C)=C2C(=O)OC2CCCC(C)C2)cc1
c.) CCSc1nnc(NC(=O)c2cc3c(s2)CCCC3)s1
Answer: a. CC(C)N(Cc1nc(-c2ccccc2)no1)C(=O)COc1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)N(Cc1nc(-c2ccccc2)no1)C(=O)COc1ccccc1
CC(C)N(Cc1nc(-c2ccccc2)no1)C(=O)COc1ccccc1
2-phenoxy-N-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]-N-propan-2-ylacetamide